Clinical Trial: A Clinical Trial of HRS-3095 in Patients With Chronic Spontaneous Urticaria

U.S., May 30 -- ClinicalTrials.gov registry received information related to the study (NCT07613866) titled 'A Clinical Trial of HRS-3095 in Patients With Chronic Spontaneous Urticaria' on May 22.

Brief Summary: The study is being conducted to evaluate the efficacy, and safety of HRS-3095 with Chronic Spontaneous in adults, and to explore the reasonable dosage of HRS-3095 for Chronic Spontaneous Urticaria.

Study Start Date: July, 2026

Study Type: INTERVENTIONAL

Condition: Chronic Spontaneous Urticaria

Intervention: DRUG: HRS-3095 Tablet

HRS-3095 tablet.

DRUG: HRS-3095 Tablet Placebo

HRS-3095 tablet placebo.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Chengdu Suncadia Medicine Co., Ltd.

Published by HT Digital Content Service...